APOLLOHOSP:NSE-Apollo Hospitals Enterprise Limited (INR)

COMMON STOCK | Medical Care Facilities | NSE

Last Closing Price

INR 5,592.95

Change

+21.95 (+0.39)%

Market Cap

INR 817.81B

Volume

1.24M

Avg Analyst Target

INR 4,331.80 (-22.55%)

Avg User Target

INR
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

Apollo Hospitals Enterprise Limited (APOLLOHOSP) Stock Analysis:
Based on the Apollo Hospitals Enterprise Limited stock forecasts from 4 analysts, the average analyst target price for Apollo Hospitals Enterprise Limited is INR 4,331.80 over the next 12 months. Apollo Hospitals Enterprise Limited’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Apollo Hospitals Enterprise Limited is Slightly Bullish , which is based on 9 positive signals and 7 negative signals. At the last closing, Apollo Hospitals Enterprise Limited’s stock price was INR 5,592.95. Apollo Hospitals Enterprise Limited’s stock price has changed by -108.10 % over the past week, +1,303.05 % over the past month and +134.02 % over the last year.

About

Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India and internationally. The company's healthcare facilities comprise primary, secondary, and tertiary care facilities. Its tertiary care hospitals provide care in approximately ...Read More

Company Website : http://www.apollohospitals.com

Address : Sunny Side Building, Chennai, India, 600006

Employees : 68,496

Fiscal Year End : March

Currency: INR

Country : India

Technical Indicators

Beta : 0.64

52 Week High : 5,935.40

52 Week Low : 2,249.63

200 Day Moving Average : 3,890.87

50 Day Moving Average : 4,694.86

Shares Held By Insiders : 29.82%

Shares Held by Institutions : 50.45%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-12-02 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
MAXHEALTH:NSE Max Healthcare Institute Limit..

-0.80 (-0.21%)

 INR362.31B 78.31 39.63
FORTIS:NSE Fortis Healthcare Limited

+2.50 (+0.87%)

 INR212.63B 47.77 17.13
NH:NSE Narayana Hrudayalaya Limited

-5.65 (-0.97%)

 INR121.86B 42.61 20.32
ASTERDM:NSE Aster DM Healthcare Limited

+2.15 (+1.12%)

 INR95.91B 27.42 10.96
HCG:NSE HealthCare Global Enterprises ..

-2.25 (-0.90%)

 INR31.74B N/A 47.42
MAXINDIA:NSE Max Healthcare Institute Limit..

N/A

 INR18.42B 5.20 N/A
SHALBY:NSE Shalby Limited

+4.25 (+3.10%)

 INR14.80B 25.71 11.21
INDRAMEDCO:NSE Indraprastha Medical Corporati..

+7.45 (+9.58%)

 INR7.09B 12.94 5.40
LOTUSEYE:NSE Lotus Eye Hospital and Institu..

+0.05 (+0.10%)

 INR1.00B 30.68 20.15

ETFs Containing APOLLOHOSP

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 131.61% 100% A+ 86% B
Dividend Return 0.12% 33% F 3% F
Total Return 131.73% 100% A+ 86% B
Trailing 12 Months  
Capital Gain 134.02% 100% A+ 80% B-
Dividend Return 0.13% 33% F 3% F
Total Return 134.15% 100% A+ 80% B-
Trailing 5 Years  
Capital Gain 366.88% 100% A+ 91% A-
Dividend Return 1.90% 50% F 21% F
Total Return 368.78% 100% A+ 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 39.09% 100% A+ 81% B-
Dividend Return 0.39% 20% F 31% F
Total Return 39.48% 100% A+ 81% B-
Risk Return Profile  
Volatility (Standard Deviation) 53.79% 38% F 53% F
Risk Adjusted Return 73.40% 100% A+ 90% A-
Market Capitalization 817.81B 100% A+ 96% A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 78.18 25% F 11% F
Price/Book Ratio 15.42 11% F 5% F
Price / Cash Flow Ratio 64.22 22% F 8% F
EV/EBITDA 36.73 33% F 17% F
Management Effectiveness  
Return on Equity 24.41% 89% B+ 85% B
Return on Invested Capital 6.78% 89% B+ 55% F
Return on Assets 7.49% 78% C+ 72% C-
Debt to Equity Ratio 53.74% 13% F 24% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.64 63% D 73% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
New Post

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.